CollPlant Biotechnologies (CLGN) Q4 2024 Earnings
CLGN·Reported March 26, 2025·Before market open
CollPlant Biotechnologies reported Q4 2024 revenue of $164.0K, beat analyst consensus of $100.0K by $64.0K. Diluted EPS came in at $-0.34, beat the $-0.42 consensus by $0.08.
Revenue
$164.0Kbeat by $64.0K
Consensus: $100.0KDiluted EPS
$-0.34beat by $0.08
Consensus: $-0.42
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2024 Earnings FAQ
Common questions about CollPlant Biotechnologies's Q4 2024 earnings report.
CollPlant Biotechnologies (CLGN) reported Q4 2024 earnings on March 26, 2025 before market open.
CollPlant Biotechnologies reported revenue of $164.0K and diluted EPS of $-0.34 for Q4 2024.
Revenue beat the consensus estimate of $100.0K by $64.0K. EPS beat the consensus estimate of $-0.42 by $0.08.